Using a 135Sjmethionine labeling/immunoprecipitation technique, we have previously shown that cultured skin fibroblast from three patients with short chain acyl-CoA dehydrogenase (SCAD) deficiency each synthesize a normal-sized (41 kD) variant SCAD in an amount comparable to that of normal cells. In the current study, these same cell lines were reexamined with immunoblot analysis. In one cell line (YH2065) no SCAD protein was detectable. In the other two deficient cell lines, the amount of variant SCAD was similar to, or only slightly less than, normal. These results suggested that SCAD-YH2065 is labile. In the pulse-labeling experiments, labeled SCAD was readily detectable for at least 30 h in a normal control and two other SCAD-deficient cell lines. In contrast, the labeled SCAD band in YH2065 cells was barely detectable at 6 h and undetectable at 20 h. [35SjMethionine-labeling in the presence of rhodamine 6G demonstrated that SCAD-YH2065 was synthesized as a 44-k) precursor and imported normally into mitochondria, as were the normal SCAD and two other variant SCADS, excluding the possibility that SCAD-YH2065 is a truncated precursor that cannot be imported into mitochondria. These results indicate that the mutations responsible for SCAD deficiency are heterogeneous, and emphasize the importance of using both radiolabeling and immunoblotting when evaluating such genetic defects at the protein level.
Introduction
Hereditary short chain acyl-coenzyme A dehydrogenase (SCAD)I deficiency is an inborn error of fatty acid metabolism that has recently been described in three infants (1, 2) . The main clinical features in two of them were neonatal metabolic acidosis and urinary excretion of ethylmalonate. One of them died in the neonatal period (1) . The third patient had a history of progressive skeletal muscle weakness, developmental delay, and muscle carnitine deficiency (2) . Butyryl-CoA dehydro-genating activity in cultured fibroblasts from these three patients, assayed in the presence of anti-medium chain acyl-CoA dehydrogenase antibody, was found to be < 11% of controls, indicating a specific SCAD deficiency (1, 2) .
SCAD (EC 1.3.99.2) is one of five enzymes belonging to the Acyl-CoA Dehydrogenase Family (3, 4) . It catalyzes the first reaction in the f-oxidation of short chain fatty acids. Like other members of this gene family, SCAD is a tetrameric mitochondrial flavoprotein. Its subunit size is 41 kD (5) . It is encoded in the nucleus as a 44-kD precursor, transported into mitochondria, and proteolytically processed to the 41 -kD mature form (6) . We have recently demonstrated, using labeling with [35S]methionine, immunoprecipitation, and electrophoretic analysis, that the cells from the three SCAD-deficient patients each produced an SCAD protein of normal size, suggesting that-the biochemical defect in each of these patients is due to a point mutation in the SCAD gene (7) . No genetic heterogeneity was detected. These results, however, did not exclude the possibility that more than one type of variant SCAD allele exists.
To further investigate this possibility, we studied variant SCAD in fibroblasts from the same three SCAD-deficient patients using immunoblot , the membrane was incubated for 1 h with a 1:300 dilution ofanti-rat SCAD antibody. The membrane was washed, then incubated with a 1:3,000 dilution of goat anti-rabbit IgG alkaline phosphatase conjugate (Bio-Rad Laboratories). For color development of alkaline phosphatase, the nitrocellulose membrane was immersed in carbonate buffer (0.1 M NaHCO3, 1.0 mM MgCl2, pH 9.8) containing 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (Bio-Rad Laboratories).
Pulse-labeling offibroblasts with [3sS]methionine and pulse-chase.
Confluent monolayers of fibroblasts in two 25-cm2 dishes were labeled with [35S]methionine (100 MCi) in 2.5 ml of labeling medium containing 60% Puck's saline G, 15% dialyzed FCS, and 10% glucose as previously described (8) . The dishes were incubated at 37°C for 1 h. After removing the labeling medium, cells were washed twice with PBS and then harvested by adding 1 ml of NETS/methionine buffer (150 mM NaCl, 10 mM EDTA, pH 7.4,0.5% Triton X-100, 0.25% SDS, and 2% unlabeled methionine) to each dish. When rhodamine 6G was used, it was added to the medium in a 75-cm2 dish at a final concentration of 2.1 MM, 30 min before the medium was replaced with the labeling medium containing [35S]methionine. The dish was then incubated at 37°C for 1 h in the labeling medium containing the same concentration of rhodamine 6G. In the chase experiments, the labeling of cells was performed as described above. After a 1-h pulse, the medium was replaced with growth medium containing no label, and the cells were harvested at 6, 20, and 30 h, respectively. The labeled cells were rapidly washed twice with PBS, and then extracted as described above.
Results
Immunoblot analysis. Fig. 1 shows the immunoblot of SDS-PAGE of control purified rat liver SCAD and fibroblast extracts from two normal and three SCAD-deficient cell lines. 6 and 20 h in the normal cell line. However, the signal was quite strong at 20 h ( Fig. 2 A, lanes 1, 2, and 3) and still detectable at 30 h ( Fig. 2 B,  lane 4) . In YH1988 and 1950, the SCAD band was readily detectable up to 30 h as in the case ofthe normal cells (Fig. 2 B,  lanes 5-12) . In line YH2065, immediately after the 1 h pulselabeling, a SCAD protein was synthesized in the amount comparable to that of the normal control and the two other SCAD-deficient cell lines (Fig. 2 A, lane 4) . However, it was barely detectable as early as 6 h after chase, and completely disappeared after a 20-h chase (Fig. 2 A, lanes 5 and 6) .
Electrophoretic analysis ofSCAD labeled with [35S]methio-
nine. In order to study the synthesis of the SCAD precursor in normal and mutant cells, labeling was carried out with [35S]_ methionine in the presence of rhodamine 6G. Rhodamine 6G, an inhibitor of the mitochondrial energy metabolism, is known to inhibit the mitochondrial uptake of the precursor of nuclear encoded mitochondrial enzymes, leading to the suppression of their posttranslational processing (6, 9, 10) . When normal cells were labeled in the absence of rhodamine 6G, a sharp band with a molecular mass of 41 kD was observed as previously reported (Fig. 3 A, lane 1) . When celllabeling was performed in the presence of rhodamine 6G, the intensity ofthe 41-kD band greatly decreased and a new 44-kD band was detected (Fig. 3 A, lane 3) . Both 41-and 44-kD bands were not detectable when an excessive amount (7 gg) of pure rat SCAD was added to each immunoprecipitation mixture before the addition of the antibody (Fig. 3 A, lanes 2 and 4) . This confirms that the 41-and 44-kD bands are indeed the mature and precursor SCAD, respectively. When the SCAD synthesis was studied in the three SCAD-deficient cell lines using the same method, 41-and 44-kD bands were detected in the absence and presence of rhodamine 6G, respectively, as seen with normal cells (Fig. 3 B, lanes 3-8) . The likely that the SCAD deficiency in the three mutant cell lines studied here is probably due to a point mutation in each case. It is obvious, however, that at least the mutation in YH2065 is distinctly different from those in the other two cell lines, demonstrating molecular heterogeneity in the mutation of SCAD gene. This information will be useful for further pinpointing the mutation in each cell line using the polymerase chain reaction (1 1).
The results from the present study are also important, emphasizing that the two immunochemical methods used in these experiments examine somewhat different aspects of the protein under study. The [35S]methionine-labeling/ immunoprecipitation technique reflects the cells' ability to synthesize protein, since an extremely small amount of newly synthesized protein can be detected due to the extremely high specific activity of [35S]methionine. In contrast, immunoblot analysis represents the amount of protein present within the cells in the steady state. Most previous studies of proteins produced by mutant cell lines have been performed using only one of these methods. This can lead to an obvious wrong conclusion about the nature of such a mutation. For instance, if the variant SCAD in YH2065 had only been tested by immunoblot analysis, the complete absence of SCAD protein could be interpreted as being due to a gross deletion, a transcriptional mutant, or a frame-shift point mutation leading to a premature stop codon near the amino terminus. Thus, investigators must use both methods when studying such inborn errors of metabolism at the protein level.
